PolyVascular
Houston, US · Delaware corporation
PolyVascular develops a polymer-based transcatheter pulmonary heart valve for pediatric patients with congenital heart conditions. The medical device company focuses on providing durable, minimally invasive valve replacements for children.
Founders & leadership
WC
Will CliftoninCOO / Operational & Clinical Consultant (MD)
CC
Cindy ClagueinVP of Research & Development (PhD)
KB
Katie BalesinVP, Investor Relations
PS
Paul SwegleNamed on SEC filing
DH
Daniel HarringtonCo-Founder (PhD)
KC
Kwonsoo ChunNamed on SEC filing
HJ
Henri JustinoCo-Founder (MD)
TS
Tim SmokoffNamed on SEC filing
DS
Doug SmithController
Reported raises · per SEC filings
Form D private placements$795K disclosed across 1 round · 2023
▶$795KraisedJul 2023 · 5 investors · Other Health CareRule 506(b)
▶$795KraisedJul 2023 · 5 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Paul SwegleExecutive Officer
- Daniel HarringtonDirector
- Kwonsoo ChunDirector
- Henri JustinoDirector
- Tim SmokoffExecutive Officer, Director
- Offering amount
- $2M
- Amount sold
- $795K
- Minimum investment
- $100K
- First sale
- Jun 2023
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Competitors · 5
by search overlap
Rf Surgical16 shared keywordsMedtronic is a healthcare technology company that develops medical devices and technologies — including pacemakers, robotic-assisted surgery systems, and AI-driven health tools — used by doctors, scientists, and engineers to treat pain and disease. It works with clinicians to create solutions aimed at treating conditions such as AFib.
Edwards Lifesciences12 shared keywordsEdwards Lifesciences develops innovative medical technologies for treating cardiovascular disease, focusing on structural heart interventions. The company serves patients and healthcare providers globally through partnerships with clinicians and healthcare stakeholders.
Foldax12 shared keywordsFoldax develops heart valve replacement technology leveraging polymer expertise and biologic design. The company targets patients who require valve replacement, particularly young women with rheumatic disease in developing countries and aging patients in developed markets facing multiple surgeries.
Boston Scientific11 shared keywordsBoston Scientific supports external researcher-initiated studies through its Investigator Sponsored Research program, which funds independent investigations addressing disease understanding and treatment gaps of interest to the medical community.
4C Medical Technologies7 shared keywords4C Medical develops minimally invasive medical devices for structural heart disease, including mitral and tricuspid valve treatments. The company serves interventional cardiologists and patients requiring catheter-based cardiac interventions.
Companies competing with PolyVascular for the same Google search keywords, organic and paid, via search-intersection analysis.
Frequently asked questions
- What does PolyVascular do?
- PolyVascular develops a polymer-based transcatheter pulmonary heart valve for pediatric patients with congenital heart conditions. The medical device company focuses on providing durable, minimally invasive valve replacements for children.
- How much funding has PolyVascular raised?
- PolyVascular has disclosed $795K raised across 1 round.
- Where is PolyVascular headquartered?
- PolyVascular is headquartered in Houston, US.